CME Group director William Shepard buys $71,994 in common stock

Published 28/03/2025, 00:26
CME Group director William Shepard buys $71,994 in common stock

CHICAGO—William R. Shepard, a director at CME Group Inc. (NASDAQ:CME), recently purchased shares of the company in a transaction dated March 26, 2025. The purchase comes as CME trades near its 52-week high of $267.91, with the stock delivering a robust 27% return over the past year. According to a filing with the Securities and Exchange Commission, Shepard acquired a total of $71,994 worth of common stock at a price of $262.62 per share.

The transaction included the acquisition of 274.14 shares, with 262.56 shares acquired indirectly through a trust and 11.58 shares purchased directly. Following these transactions, Shepard’s total holdings amount to 257,060.99 shares held indirectly and 2,443.47 shares held directly. For deeper insights into insider trading patterns and comprehensive analysis, InvestingPro subscribers can access detailed research reports and trading signals.

The purchases reflect shares acquired through a dividend reinvestment plan administered by Shepard’s broker. CME Group has maintained dividend payments for 23 consecutive years, with a current yield of 4.12% and dividend growth of 11.92% over the last twelve months.

In other recent news, CME Media Enterprises B.V. (CME) saw its long-term corporate family rating upgraded by Moody’s from B1 to Ba3, reflecting improved financial performance and reduced leverage. The company’s revenue grew by 11% in 2024, driven by significant increases in TV advertising, carriage fees, and Voyo subscription revenue. Despite strategic investments, CME’s OIBDA also grew by 6% during the same period. In the realm of derivatives, CME Group launched Solana futures contracts, expanding its cryptocurrency offerings and highlighting institutional interest in digital assets. Additionally, CME Group plans to introduce Bloomberg Commodity Subindex futures, which will cover key sectors such as Agriculture and Energy, pending regulatory approval. Erste Group initiated coverage of CME Group stock with a Buy rating, citing potential earnings surprises due to underestimated forecasts and a broad array of risk management tools. Meanwhile, Keefe, Bruyette & Woods maintained a Market Perform rating on CME Group, noting that its average daily volume for the first quarter of 2025 is tracking above estimates. These developments underscore the ongoing strategic expansion and financial resilience of both CME Media Enterprises and CME Group.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.